Boyan Vesselinov Litchev - Net Worth and Insider Trading

Boyan Vesselinov Litchev Net Worth

The estimated net worth of Boyan Vesselinov Litchev is at least $978 dollars as of 2024-12-27. Boyan Vesselinov Litchev is the Chief Medical Officer of Indaptus Therapeutics Inc and owns about 1,150 shares of Indaptus Therapeutics Inc (INDP) stock worth over $978. Details can be seen in Boyan Vesselinov Litchev's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boyan Vesselinov Litchev has not made any transactions after 2022-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Boyan Vesselinov Litchev

To

Boyan Vesselinov Litchev Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Boyan Vesselinov Litchev owns 1 companies in total, including Indaptus Therapeutics Inc (INDP) .

Click here to see the complete history of Boyan Vesselinov Litchev’s form 4 insider trades.

Insider Ownership Summary of Boyan Vesselinov Litchev

Ticker Comapny Transaction Date Type of Owner
INDP Indaptus Therapeutics Inc 2022-12-01 Chief Medical Officer

Boyan Vesselinov Litchev Latest Holdings Summary

Boyan Vesselinov Litchev currently owns a total of 1 stock. Boyan Vesselinov Litchev owns 1,150 shares of Indaptus Therapeutics Inc (INDP) as of December 1, 2022, with a value of $978.

Latest Holdings of Boyan Vesselinov Litchev

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INDP Indaptus Therapeutics Inc 2022-12-01 1,150 0.85 978

Holding Weightings of Boyan Vesselinov Litchev


Boyan Vesselinov Litchev Form 4 Trading Tracker

According to the SEC Form 4 filings, Boyan Vesselinov Litchev has made a total of 1 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Indaptus Therapeutics Inc is the acquisition of 1,150 shares on December 1, 2022, which cost Boyan Vesselinov Litchev around $2,519.

Insider Trading History of Boyan Vesselinov Litchev

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Boyan Vesselinov Litchev Trading Performance

GuruFocus tracks the stock performance after each of Boyan Vesselinov Litchev's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Boyan Vesselinov Litchev is -5.03%. GuruFocus also compares Boyan Vesselinov Litchev's trading performance to market benchmark return within the same time period. The performance of stocks bought by Boyan Vesselinov Litchev within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Boyan Vesselinov Litchev's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Boyan Vesselinov Litchev

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -13.17 LIMIT LIMIT LIMIT LIMIT LIMIT

Boyan Vesselinov Litchev Ownership Network

Ownership Network List of Boyan Vesselinov Litchev

No Data

Ownership Network Relation of Boyan Vesselinov Litchev

Insider Network Chart

Boyan Vesselinov Litchev Owned Company Details

What does Indaptus Therapeutics Inc do?

Who are the key executives at Indaptus Therapeutics Inc?

Boyan Vesselinov Litchev is the Chief Medical Officer of Indaptus Therapeutics Inc. Other key executives at Indaptus Therapeutics Inc include 10 percent owner Glen R. Anderson , Chief Medical Officer Roger J. Waltzman , and director & Chief Executive Officer Jeffrey A Meckler .

Indaptus Therapeutics Inc (INDP) Insider Trades Summary

Over the past 18 months, Boyan Vesselinov Litchev made no insider transaction in Indaptus Therapeutics Inc (INDP). Other recent insider transactions involving Indaptus Therapeutics Inc (INDP) include a net purchase of 103,352 shares made by Glen R. Anderson ,

In summary, during the past 3 months, insiders sold 0 shares of Indaptus Therapeutics Inc (INDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Indaptus Therapeutics Inc (INDP) were sold and 103,352 shares were bought by its insiders, resulting in a net purchase of 103,352 shares.

Indaptus Therapeutics Inc (INDP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Indaptus Therapeutics Inc Insider Transactions

No Available Data

Boyan Vesselinov Litchev Mailing Address

Above is the net worth, insider trading, and ownership report for Boyan Vesselinov Litchev. You might contact Boyan Vesselinov Litchev via mailing address: 13357 Russet Leaf Ln., San Diego Ca 92129.

Discussions on Boyan Vesselinov Litchev

No discussions yet.